SynthesisFrontiers in immunology2025

Dual-target immunotherapies in NSCLC: a systematic review and meta-analysis of randomized clinical trials.

Yike Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.